XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 45.34

Change

0.00 (0.00)%

Market Cap

CAD 0.55B

Volume

805.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-22 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+0.92 (+0.61%)

CAD 20.69B
ZSP:CA BMO S&P 500

+0.75 (+0.80%)

CAD 18.86B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.43 (+0.69%)

CAD 11.36B
VUN:CA Vanguard US Total Market

+0.67 (+0.59%)

CAD 11.07B
XUS:CA iShares Core S&P 500 Index ETF

+0.40 (+0.75%)

CAD 8.43B
HXS:CA Global X S&P 500 Corporate Cla..

+0.57 (+0.65%)

CAD 4.68B
VSP:CA Vanguard S&P 500 CAD hedged

+0.72 (+0.75%)

CAD 4.03B
QUU:CA Mackenzie US Large Cap Equity ..

+0.56 (+0.23%)

CAD 3.49B
XUU:CA iShares Core S&P US Total Mark..

+0.45 (+0.71%)

CAD 3.43B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.52 (+0.97%)

CAD 3.26B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 35.67% 86% B+ 87% B+
Dividend Return 0.80% 24% F 10% F
Total Return 36.46% 88% B+ 85% B
Trailing 12 Months  
Capital Gain 34.78% 81% B- 86% B+
Dividend Return 1.12% 31% F 11% F
Total Return 35.90% 81% B- 84% B
Trailing 5 Years  
Capital Gain 98.60% 77% C+ 87% B+
Dividend Return 6.60% 17% F 11% F
Total Return 105.20% 75% C 85% B
Average Annual (5 Year Horizon)  
Capital Gain 14.75% 76% C+ 79% B-
Dividend Return 15.59% 74% C 76% C+
Total Return 0.84% 22% F 39% F
Risk Return Profile  
Volatility (Standard Deviation) 15.34% 38% F 55% F
Risk Adjusted Return 101.64% 66% D+ 95% A
Market Capitalization 0.55B 53% F 61% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.